ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,836.22
      0.16%
      US Tech 100
      20,369.60
      0.73%
      Dow Jones
      42,297.12
      0.86%
      Brent Oil
      80.335
      0.07%
      Bitcoin
      96,906.65
      2.52%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Novo Resources Corp (NVO) Quote

      Novo Resources Corp

      Novo Resources Corp (NVO)

      Novo Nordisk
      Novo Resources Corp
      Novo Resources Corp
      0.097
      0.003
      (3.19%)
      Closed January 14 12:00AM
      Delayed by 20 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.097
      Bid
      0.097
      Ask
      0.10
      Volume
      100,252
      0.096 Day's Range 0.10
      0.081 52 Week Range 0.195
      Market Cap
      34.247M
      Previous Close
      0.094
      Open
      0.096
      Last Trade
      245
      @
      0.097
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      158,718
      Shares Outstanding
      353,060,847
      Dividend Yield
      -
      PE Ratio
      -45.71
      Earnings Per Share (EPS)
      -0
      Revenue
      -
      Net Profit
      -1.24M

      About Novo Resources Corp

      Sector
      Computer Related Svcs, Nec
      Industry
      Gold Ores
      Website
      www.nvoi.com.au
      Headquarters
      Sydney, New South Wales, Aus
      Founded
      2016
      Novo Resources Corp is listed in the Computer Related Svcs sector of the Australian Stock Exchange with ticker NVO. The last closing price for Novo Resources was AUD0.09. Over the last year, Novo Resources shares have traded in a share price range of AUD 0.081 to AUD 0.195.

      Novo Resources currently has 353,060,847 shares outstanding. The market capitalization of Novo Resources is AUD33.19 million. Novo Resources has a price to earnings ratio (PE ratio) of -45.71.

      Ask ADVFN Intelligence (AI)

      NVO Latest News

      More News

      Novo Nordisk Makes Victoza(R) Commercially Available in the United States

      PRINCETON, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO) today announced that Victoza® (liraglutide [rDNA origin] injection) is now available in the United States. Victoza is...

      February 16 2010
      PR Newswire (US)

      Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

      Second Consecutive Year for Diabetes Care Leader PRINCETON, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Novo Nordisk, a global healthcare company focusing on diabetes care, has been named to FORTUNE...

      January 21 2010
      PR Newswire (US)

      Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

      - Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 14 /PRNewswire/ -- A new analysis found that the cost of diabetes and pre-diabetes...

      January 14 2010
      PR Newswire (US)

      /K I L L K I L L K I L L - National Changing Diabetes Program/

      We are advised by National Changing Diabetes Program that journalists and other readers should disregard the news release, Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007...

      January 13 2010
      PR Newswire (US)

      Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

      - Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 13 /PRNewswire/ -- A new analysis found that the cost of diabetes and pre-diabetes...

      January 13 2010
      PR Newswire (US)

      FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

      Study Shows Relief of Postmenopausal Symptoms PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose...

      December 02 2009
      PR Newswire (US)

      Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

      Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the United States will almost double over the next 25...

      November 27 2009
      PR Newswire (US)

      Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

      Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the United States will almost double over the next 25...

      November 27 2009
      PR Newswire (US)

      Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

      Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care PRINCETON, N.J., Nov. 19 /PRNewswire/ -- Nearly one-third of doctors surveyed said they...

      November 19 2009
      PR Newswire (US)

      Novo Nordisk is Changing Possibilities in Hemophilia

      Expanded Web Site and Facebook Wall Provide Resources to Hemophilia with Inhibitors Community PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced the re-launch of its...

      October 30 2009
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0011.041666666670.0960.10.093548310.09517964DE
      4-0.001-1.020408163270.0980.10.092802380.09545346DE
      12-0.003-30.10.140.0811587180.09845186DE
      26-0.013-11.81818181820.110.140.0811375620.09941773DE
      52-0.073-42.94117647060.170.1950.0811207500.11557271DE
      156-0.123-55.90909090910.220.2750.0811653480.16194077DE
      2600.081506.250.0160.2750.00512708220.02258742DE

      NVO - Frequently Asked Questions (FAQ)

      What is the current Novo Resources share price?
      The current share price of Novo Resources is AUD 0.097
      How many Novo Resources shares are in issue?
      Novo Resources has 353,060,847 shares in issue
      What is the market cap of Novo Resources?
      The market capitalisation of Novo Resources is AUD 33.19M
      What is the 1 year trading range for Novo Resources share price?
      Novo Resources has traded in the range of AUD 0.081 to AUD 0.195 during the past year
      What is the PE ratio of Novo Resources?
      The price to earnings ratio of Novo Resources is -45.71
      What is the reporting currency for Novo Resources?
      Novo Resources reports financial results in AUD
      What is the latest annual profit for Novo Resources?
      The latest annual profit of Novo Resources is AUD -1.24M
      What is the registered address of Novo Resources?
      The registered address for Novo Resources is LEVEL 5, 126 PHILLIP STREET, SYDNEY, NEW SOUTH WALES, 2000
      What is the Novo Resources website address?
      The website address for Novo Resources is www.nvoi.com.au
      Which industry sector does Novo Resources operate in?
      Novo Resources operates in the GOLD ORES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WLDWellard Limited
      AUD 0.15
      (105.48%)
      		6.79M
      EXTODExcite Technology Services Ltd
      AUD 0.002
      (100.00%)
      		1.14M
      LNRLanthanein Resources Ltd
      AUD 0.003
      (50.00%)
      		600k
      APCOAPC Minerals Ltd
      AUD 0.003
      (50.00%)
      		405.97k
      HWKOHawk Resources Ltd
      AUD 0.01
      (42.86%)
      		1
      NHEOANoble Helium Ltd
      AUD 0.004
      (-69.23%)
      		769.23k
      MMROMEC Resources Ltd
      AUD 0.001
      (-50.00%)
      		4.88M
      RADORadiopharm Theranostics Ltd
      AUD 0.004
      (-42.86%)
      		922.36k
      KNGOKingsland Minerals Ltd
      AUD 0.015
      (-34.78%)
      		37.5k
      CRIOCritica Ltd
      AUD 0.002
      (-33.33%)
      		1.67M
      MTLMantle Minerals Limited
      AUD 0.001
      (0.00%)
      		245.05M
      MRQOMRG Metals Limited
      AUD 0.001
      (0.00%)
      		104.12M
      SGRStar Entertainment Group Limited
      AUD 0.14
      (12.00%)
      		53.77M
      OB1Orbminco Ltd
      AUD 0.002
      (0.00%)
      		34.7M
      TMGTrigg Minerals Ltd
      AUD 0.048
      (-2.04%)
      		33.55M

      Discussion

      View Full Feed
      Golden Cross Golden Cross 5 minutes ago
      $ILLR Many Reasons To Like Triller Now!

      ~ Launch of Triller 5.0 App.
      ~ New Streaming Acquisition News Soon
      ~ Multiple Revenue Streams.
      ~ New CEO of Triller App is former TikTok executive Sean Kim.
      ~ TikTok US ban starts 1-19, 2025. Federal court just upheld
      ILLR
      Golden Cross Golden Cross 6 minutes ago
      💎 $ILLR Many Reasons To Like Triller Now⬇️

      ~ Launch of Triller 5.0 App.
      ~ New Streaming Acquisition News Soon
      ~ Multiple Revenue Streams.
      ~ New CEO of Triller App is former TikTok executive Sean Kim.
      ~ TikTok US ban starts 1-19, 2025. Federal cour
      ILLR
      kspar1 kspar1 7 minutes ago
      Wow! I had no idea the JPM conference in San Francisco is as energetic as this link reads, including the partnership announcements. Will be fun to see how Anavex is positioned. The conference supposed to generate $92M for the city.
      https://www.fiercebiotech.com/biotech/jpm25-day-1-fierce-bio
      JPM
      Frankestin Frankestin 8 minutes ago
      Truist Securities raises PT to $180 from $150 😮
      The next two weeks will be eventful
      AXS-07, a candidate for the acute treatment of migraines, with expectations for regulatory approval
      NDA for AXS-14 for fibromyalgia... maybe yes or maybe no
      AXSM
      Number sleven Number sleven 12 minutes ago
      https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
      Sleven,
      AMRN
      price_and_volume price_and_volume 16 minutes ago
      "Right news" gonna get $175-350MM market cap? LOL!

      Omg what a maroon.
      VXIT
      The Danish Dude The Danish Dude 16 minutes ago
      Nice and interesting analysis, but completely irrelevant >!

      I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

      I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

      1
      NWBO
      lakers17 lakers17 18 minutes ago
      MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.
      MTC
      Golden Cross Golden Cross 21 minutes ago
      Loading Zone Here! $ASII
      ASII
      Hi_Lo Hi_Lo 29 minutes ago
      Where is the CSE press release filing?

      TWOH has been halted for more than a week now and the CSE press release is still missing.

      Could the run up before the halt be the problem?

      Could some people have been tipped off before the run up?

      Coul
      TWOH
      SkeBallLarry SkeBallLarry 37 minutes ago
      https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
      Dodger1 Dodger1 39 minutes ago
      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
      AABB
      jondoeuk jondoeuk 42 minutes ago
      NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

      https://i.postimg.cc/fyWcxcwj/download.png

      * It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
      HPQ
      marcis marcis 43 minutes ago
      I was just thinking the same thing

      Go bother those serial OTC stock hijackers
      ( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
      ( not you Prophet, to the shills )
      Save those investors
      RDAR
      No-Quarter No-Quarter 44 minutes ago
      Good to know, thx!
      LetGoodTimesRoll LetGoodTimesRoll 44 minutes ago
      The criminality surrounding BLUE Sheets data is rampant...

      https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
      FOXO
      Seminole Red Seminole Red 45 minutes ago
      https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
      Bubae Bubae 45 minutes ago
      New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
      ILLR
      meshcan meshcan 47 minutes ago
      Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

      CC: NASDAC2020
      ELTP
      PlaneReflection PlaneReflection 47 minutes ago
      Remember when you said it won't pass $2 again?

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

      Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
      FNMA
      eagle8 eagle8 49 minutes ago
      ATLnsider
      @ATLnsider
      Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi
      NWBO
      PROPHET-of-PROFITS PROPHET-of-PROFITS 49 minutes ago
      The old CEO of rdar has a new stock already to transfer all of his garbage into. But you watch the bearish comments here Will Never follow Jacob to that new stock where efforts should be made to protect people from making a bad investment. Negative bearish comments and all the effort to create them
      RDAR
      Pickme2 Pickme2 50 minutes ago
      The only proof here is you constantly saying this is the best setup and challenge...yet it keeps going down down from .31 cents to .03 ...now .05  and despite the company saying this S-1 offering filled with the SEC will cause dilution and shareholders will have a hard time selling...you continue to
      ATMH

      Your Recent History

      ASX
      NVO
      Novo Resources
      TG
      SMI
      Tian An Medicare
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads